Features

Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique challenges? Matt Fellows speaks...

As the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit...

Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following the Supreme Court...

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as we slowly...

Kay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of accurate diagnosis. She...

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how...

2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 bringing a host...

In November 2018, a Phase 2 clinical trial foundthat 76% of patients who underwent MDMA-assisted psychotherapy no longer had PTSD, twelve months...

Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, and discusses what...

Michael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey which suggests that...